EN DE
STOCK COMPARISON

Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A vs Jd Health International Inc: Fair Value & Quality

Both stocks run through our valuation models. Here is how Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) and Jd Health International Inc (6618) compare, as of Sep 5, 2026.

As of Sep 5, 2026, Fair Value Calculator sees Jd Health International Inc as the less overvalued of the two: Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A trades at ¥14.40 versus a fair value of ¥10.05 (-30%), while Jd Health International Inc trades at HK$37.06 versus HK$33.31 (-10%).
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
301408.SHE · CNY · Consumer Staples
-30%
upside to fair value
overvalued
Price¥14.40
Fair Value¥10.05
Quality57/100
Jd Health International Inc
6618.HK · HKD · Health Care
-10%
upside to fair value
overvalued
PriceHK$37.06
Fair ValueHK$33.31
Quality72/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Anhui Huaren Health Pharmaceutical Co. Ltd. Cl AJd Health International Inc
Valuation
27.2×P/E (TTM)17.6×
1.11×P/S (TTM)1.48×
2.98×P/B1.81×
12.5×EV/EBITDA19.4×
—PEG1.26×
−30.2%Fair value upside−10.1%
0.7%Dividend yield—
¥0.10Dividend per share—
Profitability
9%Operating margin4%
1.42×EBIT margin trend (5Y)—
11%Return on equity9%
5%Return on assets3%
Growth
12%Revenue growth (YoY)28%
18.9%Avg. growth/yr (3Y)16.3%
—Avg. growth/yr (5Y)30.5%
+19.2%Value creation/yr+61.5%
Balance & size
13.7×Interest coverage (EBIT/interest)342.2×
0.19×Debt / equity—
$933MMarket cap$14B
healthyGrowth qualityhealthy
Valuation multiples (P/E, P/S, P/B, EV/EBITDA) are shown but not scored here: the two companies sit in different sectors, and multiples only compare fairly between similar business models. PEG stays scored, as it relates the P/E to growth.

Even match: 3 to 3 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Anhui Huaren Health Pharmaceutical Co. Ltd. Cl Aof which business quality 60 · market factors 31 Jd Health International Incof which business quality 74 · market factors 22
ProfitabilityMargins and returns on capital today
47
47
Quality GrowthAre margins and returns improving?
72
80
CashflowEarnings quality: real cash, not paper profit
74
76
Fin. StrengthBalance sheet, leverage, solvency risk
72
100
InvestmentDisciplined investing over empire-building
32
66
Low VolatilityCalm price path (market factor)
43
44
MomentumPrice trend over the last 3–12 months (market factor)
28
16
52W MomentumDistance to the 52-week high (market factor)
23
7
Net IssuanceBuybacks instead of dilution
52
73

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyAnhui Huaren Health Pharmaceutical Co. Ltd. Cl APrice ¥14.40Jd Health International IncPrice HK$37.06
DCF Models+125%above the price¥32.46+90%above the priceHK$70.32
Earnings-Based-31%below the price¥9.93+38%above the priceHK$51.28
Multiples-14%close to the price¥12.42-23%below the priceHK$28.65
Asset-Based-76%below the price¥3.51-66%below the priceHK$12.62
Growth DCF+160%above the price¥37.41+110%above the priceHK$77.68
Economic Profit-32%below the price¥9.77-44%below the priceHK$20.89
Growth Earnings-7%close to the price¥13.41+89%above the priceHK$70.00
Minimum-76%below the price¥3.51-66%below the priceHK$12.62
Maximum+160%above the price¥37.41+110%above the priceHK$77.68
Median-14%close to the price¥12.42+38%above the priceHK$51.28
Geometric mean-9%close to the price¥13.17+6%close to the priceHK$39.43

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A: 9 of 24 models see the stock below the current price.

Jd Health International Inc: 9 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
Bear ¥7.53Fair Value ¥10.05Bull ¥12.56
¥14.40 = current price (white tick)
Jd Health International Inc
Bear HK$25.38Fair Value HK$33.31Bull HK$39.19
HK$37.06 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A · Consumer Staples

Quality score57 · above median
Fair value upside-30% · below median

Jd Health International Inc · Health Care

Quality score72 · Top 25%
Fair value upside-10% · above median

Bottom line

As of Sep 5, 2026, Fair Value Calculator sees Jd Health International Inc as the less overvalued of the two: Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A trades at ¥14.40 versus a fair value of ¥10.05 (-30%), while Jd Health International Inc trades at HK$37.06 versus HK$33.31 (-10%).

Jd Health International Inc has the higher quality score (72/100).

See the full analysis →
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A · Jd Health International Inc

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A

Altria vs WalmartCostco Wholesale vs AltriaCoca-Cola vs AltriaAltria vs Procter & Gamble

Related to Jd Health International Inc

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupMerck & Company vs UnitedHealth Group
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.